Advertisement

The Effects of Hormonal Contraceptives on Female Sexuality: A Review

      ABSTRACT

      Introduction

      Hormonal contraceptives can influence female sexual function.

      Aim

      The goal of this article was to provide a comprehensive review of the effects that various hormonal contraceptives may have on female sexual function.

      Methods

      A Medline search was conducted using several terms related to and including the terms contraception, oral contraceptive, female sexual function, dyspareunia, libido, and sexual desire.

      Results

      A thorough review of the effects of hormonal contraceptives on female sexual function.

      Conclusions

      The sexual side effects of hormonal contraceptives are not well studied, particularly with regard to impact on libido. There appears to be mixed effects on libido, with a small percentage of women experiencing an increase or a decrease, and the majority being unaffected. Healthcare providers must be aware that hormonal contraceptive can have negative effects on female sexuality so they can counsel and care for their patients appropriately. Burrows LJ, Basha M, and Goldstein AT. The effects of hormonal contraceptives on female sexuality: A review. J Sex Med 2012;9:2213–2223.

      Keywords

      To read this article in full you will need to make a payment
      ISSM Member Login
      Login with your ISSM username and password.
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Grimes D.A.
        • Schulz K.F.
        Nonspecific side effects of oral contraceptives: Nocebo or noise?.
        Contraception. 2011; 83: 5-9
      1. Gibbs N. Love, Sex, Freedom and the Paradox of the Pill: A Brief History of Birth Control. Kindle Edition. 2011.

      2. William A. Douglas. Griswold v. Connecticut, 381 U.S. 479 (1965). 1965.

        • Tone A.
        Devices and desires: A history of contraceptives in America.
        Hill and Wang, 2001
        • Watkins E.S.
        On the pill: A social history of oral contraceptives, 1950–1970.
        Johns Hopkins University Press, 1998
      3. Gynecologists ACoOa. Statement on contraceptive methods. Washington: The College . 1998.

        • Rivera R.
        • Yacobson I.
        • Grimes D.
        The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices.
        Am J Obstet Gynecol. 1999; 181: 1263-1269
        • Fuhrmann U.
        • Frattenmacher R.
        • Slater E.P.
        • Fritzemeier K.H.
        The novel progestin drospirenone and its natural counterpart progesterone: Biochemical profile and antiandrogenic potential.
        Contraception. 1996; 54: 243-251
        • Panzer C.
        • Wise S.
        • Fantini G.
        • Kang D.
        • Munarriz R.
        • Guay A.
        • Goldstein I.
        Impact of oral contraceptives on sex hormone‐binding globulin and androgen levels: A retrospective study in women with sexual dysfunction.
        J Sex Med. 2006; 3: 104-113
        • Devineni D.
        • Skee D.
        • Vaccaro N.
        • Massarella J.
        • Janssens L.
        • LaGuardia K.D.
        • Leung A.T.
        Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive.
        J Clin Pharmacol. 2007; 47: 497-509
        • Sitruk‐Ware R.L.
        • Menard J.
        • Rad M.
        • Burggraaf J.
        • de Kam M.L.
        • Tokay B.A.
        • Sivin I.
        • Kluft C.
        Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
        Contraception. 2007; 75: 430-437
        • White T.
        • Ozel B.
        • Jain J.K.
        • Stanczyk F.Z.
        Effects of transdermal and oral contraceptives on estrogen‐sensitive hepatic proteins.
        Contraception. 2006; 74: 293-296
        • Coenen C.M.
        • Thomas C.M.
        • Bonn G.F.
        • Hollanders J.M.
        • Rolland R.
        Changes in androgens during treatment with four low‐dose contraceptives.
        Contraception. 1996; 53: 171-176
        • Bancroft J.
        • Sherwin B.B.
        • Alexander G.M.
        • Davidson D.W.
        • Walker A.
        Oral contraceptives, androgens, and the sexuality of young women: II. The role of androgens.
        Arch Sex Behav. 1991; 20: 121-135
        • Shah M.B.
        • Hoffstetter S.
        Contraception and sexuality.
        Minerva Ginecol. 2010; 62: 331-347
        • Blanco‐Molina A.
        • Monreal M.
        Venous thromboembolism in women taking hormonal contraceptives.
        Expert Rev Cardiovasc Ther. 2010; 8: 211-215
        • Cibula D.
        • Gompel A.
        • Mueck A.O.
        • La Vecchia C.
        • Hannaford P.C.
        • Skouby S.O.
        • Zikan M.
        • Dusek L.
        Hormonal contraception and risk of cancer.
        Hum Reprod Update. 2010; 16: 631-650
        • Hannaford P.C.
        • Selvaraj S.
        • Elliott A.M.
        • Angus V.
        • Iversen L.
        • Lee A.J.
        Cancer risk among users of oral contraceptives: Cohort data from the Royal College of General Practitioner's Oral Contraception Study.
        BMJ. 2007; 335: 651
        • Hannaford P.C.
        • Iversen L.
        • Macfarlane T.V.
        • Elliott A.M.
        • Angus V.
        • Lee A.J.
        Mortality among contraceptive pill users: Cohort evidence from Royal College of General Practitioners' Oral Contraception Study.
        BMJ. 2010; 340: c927
        • Larsson G.
        • Milsom I.
        • Lindstedt G.
        • Rybo G.
        The influence of a low‐dose combined oral contraceptive on menstrual blood loss and iron status.
        Contraception. 1992; 46: 327-334
        • Kohler G.
        • Faustmann T.A.
        • Gerlinger C.
        • Seitz C.
        • Mueck A.O.
        A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis.
        Int J Gynaecol Obstet. 2010; 108: 21-25
        • Shifren J.L.
        • Avis N.E.
        Surgical menopause: Effects on psychological well‐being and sexuality.
        Menopause. 2007; 14: 586-591
        • Gold R.
        Rekindling efforts to prevent unplanned pregnancy: A matter of “equity and common sense”.
        Guttmacher Policy Rev. 2006; 9: 2-6
        • Graham C.A.
        • Sanders S.A.
        • Milhausen R.R.
        • McBride K.R.
        Turning on and turning off: A focus group study of the factors that affect women's sexual arousal.
        Arch Sex Behav. 2004; 33: 527-538
        • Harper J.
        Should dermatologists prescribes hormonal contraceptives for acne?.
        Dermatol Ther. 2009; 22: 452-457
        • Lucky A.W.
        • Henderson T.A.
        • Olson W.H.
        • Robisch D.M.
        • Lebwohl M.
        • Swinyer L.J.
        Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
        J Am Acad Dermatol. 1997; 37: 746-754
        • Redmond G.P.
        • Olson W.H.
        • Lippman J.S.
        • Kafrissen M.E.
        • Jones T.M.
        • Jorizzo J.L.
        Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: A randomized, placebo‐controlled trial.
        Obstet Gynecol. 1997; 89: 615-622
        • Bancroft J.
        • Sartorius N.
        The effects of oral contraceptives on well‐being and sexuality.
        Oxf Rev Reprod Biol. 1990; 12: 57-92
        • McCoy N.L.
        • Matyas J.R.
        Oral contraceptives and sexuality in university women.
        Arch Sex Behav. 1996; 25: 73-90
        • Sabatini R.
        • Cagiano R.
        Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives.
        Contraception. 2006; 74: 220-223
        • Kennedy T.G.
        Vaginal mucification in the ovariectomized rat in response to 5alpha‐pregnane‐3, 20‐dione, testosterone and 5alpha‐androstan‐17beta‐ol‐3‐one: Test for progestogenic activity.
        J Endocrinol. 1974; 61: 293-300
        • Kennedy T.G.
        • Armstrong D.T.
        Induction of vaginal mucification in rats with testosterone and 17beta‐hydroxy‐5alpha‐androstan‐3‐one.
        Steroids. 1976; 27: 423-430
        • Bazin S.
        • Bouchard C.
        • Brisson J.
        • Morin C.
        • Meisels A.
        • Fortier M.
        Vulvar vestibulitis syndrome: An exploratory case‐control study.
        Obstet Gynecol. 1994; 83: 47-50
        • Bouchard C.
        • Brisson J.
        • Fortier M.
        • Morin C.
        • Blanchette C.
        Use of oral contraceptive pills and vulvar vestibulitis: A case‐control study.
        Am J Epidemiol. 2002; 156: 254-261
        • Greenstein A.
        • Ben‐Aroya Z.
        • Fass O.
        • Militscher I.
        • Roslik Y.
        • Chen J.
        • Abramov L.
        Vulvar vestibulitis syndrome and estrogen dose of oral contraceptive pills.
        J Sex Med. 2007; 4: 1679-1683
        • Berglund A.L.
        • Nigaard L.
        • Rylander E.
        Vulvar pain, sexual behavior and genital infections in a young population: A pilot study.
        Acta Obstet Gynecol Scand. 2002; 81: 738-742
        • Bohm‐Starke N.
        • Johannesson U.
        • Hilliges M.
        • Rylander E.
        • Torebjork E.
        Decreased mechanical pain threshold in the vestibular mucosa of women using oral contraceptives: A contributing factor in vulvar vestibulitis?.
        J Reprod Med. 2004; 49: 888-892
        • Goldstein A.
        • Burrows L.
        • Goldstein I.
        Can oral contraceptives cause vestibulodynia?.
        J Sex Med. 2009; 7: 1585-1587
        • Lee M.
        • Morgan M.
        • Rapkin A.
        Clitoral and vulvar vestibular sensation in women taking 20 mcg ethinyl estradiol combined oral contraceptives: A preliminary study.
        J Sex Med. 2011; 8: 213-218
        • Edgardh K.
        • Abdelnoor M.
        Vulvar vestibulitis and risk factors: A population‐based case‐control study in Oslo.
        Acta Derm Venereol. 2007; 87: 350-354
        • Battaglia C.
        • Battaglia B.
        • Mancini F.
        • Busacchi P.
        • Paganotto M.C.
        • Morotti E.
        • Venturoli S.
        Sexual behavior and oral contraception: A pilot study.
        J Sex Med. 2012; 9: 550-557
        • Heiman J.R.
        • Rupp H.
        • Janssen E.
        • Newhouse S.K.
        • Brauer M.
        • Laan E.
        Sexual desire, sexual arousal and hormonal differences in premenopausal US and Dutch women with and without low sexual desire.
        Horm Behav. 2011; 59: 772-779
        • Bachmann G.
        • Oza D.
        Female androgen insufficiency: The Princeton consensus statement on definition, classification, and assessment.
        Fertil Steril. 2002; 77: 660-665
        • Dennerstein L.
        • Burrows G.
        Oral contraception and sexuality.
        Med J Aust. 1976; 1: 796-798
        • Bragonier J.R.
        Influence of oral contraception on sexual response.
        Med Aspects Hum Sex. 1976; 10: 130-143
        • Alexander G.M.
        • Sherwin B.B.
        • Bancroft J.
        • Davidson D.W.
        Testosterone and sexual behavior in oral contraceptive users and nonusers: A prospective study.
        Horm Behav. 1990; 24: 388-402
        • Caruso S.
        • Agnello C.
        • Intelisano G.
        • Farina M.
        • Di Mari L.
        • Sparacino L.
        • Cianci A.
        Prospective study on sexual behavior of women using 30 microg ethinylestradiol and 3 mg drospirenone oral contraceptive.
        Contraception. 2005; 72: 19-23
        • Skrzypulec V.
        • Drosdzol A.
        Evaluation of the quality of life and sexual functioning of women using a 30‐microg ethinyloestradiol and 3‐mg drospirenone combined oral contraceptive.
        Eur J Contracept Reprod Health Care. 2008; 13: 49-57
        • Kelly S.
        • Davies E.
        • Fearns S.
        • McKinnon C.
        • Carter R.
        • Gerlinger C.
        • Smithers A.
        Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well‐being in healthy women: A randomized, single‐blind, parallel‐group, multicentre study.
        Clin Drug Investig. 2010; 30: 325-336
        • Caruso S.
        • Agnello C.
        • Romano M.
        • Cianci S.
        • Lo Presti L.
        • Malandrino C.
        • Cianci A.
        Preliminary study on the effect of four‐phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life.
        J Sex Med. 2011; 8: 2841-2850
        • Caruso S.
        • Iraci Sareri M.
        • Agnello C.
        • Romano M.
        • Lo Presti L.
        • Malandrino C.
        • Cianci A.
        Conventional vs. extended‐cycle oral contraceptives on the quality of sexual life: Comparison between two regimens containing 3 mg drospirenone and 20 microg ethinyl estradiol.
        J Sex Med. 2011; 8: 1478-1485
        • Strufaldi R.
        • Pompei L.M.
        • Steiner M.L.
        • Cunha E.P.
        • Ferreira J.A.
        • Peixoto S.
        • Fernandes C.E.
        Effects of two combined hormonal contraceptives with the same composition and different doses on female sexual function and plasma androgen levels.
        Contraception. 2010; 82: 147-154
        • Fortenberry J.D.
        • Hensel D.J.
        The association of sexual interest and sexual behaviors among adolescent women: A daily diary perspective.
        Horm Behav. 2011; 59: 739-744
        • Davis S.R.
        • Davison S.L.
        • Donath S.
        • Bell R.J.
        Circulating androgen levels and self‐reported sexual function in women.
        JAMA. 2005; 294: 91-96
        • McCall K.
        • Meston C.
        Cues resulting in desire for sexual activity in women.
        J Sex Med. 2006; 3: 838-852
        • Cullberg J.
        • Gelli M.G.
        • Jonsson C.O.
        Mental and sexual adjustment before and after six months' use of an oral contraceptive.
        Acta Psychiatr Scand. 1969; 45: 259-276
        • Herzberg B.N.
        • Draper K.S.
        • Johnson A.L.
        • Nicol G.C.
        Oral contraceptives, depression, and libido.
        Br Med J. 1971; 3: 495-500
        • Kane Jr, F.J.
        • Daly R.J.
        • Ewing J.A.
        • Keeler M.H.
        Mood and behavioural changes with progestational agents.
        Br J Psychiatry. 1967; 113: 265-268
        • Huffer V.
        • Levin L.
        • Aronson H.
        Oral contraceptives: Depression and frigidity.
        J Nerv Ment Dis. 1970; 151: 35-41
        • Grounds D.
        • Davies B.
        • Mowbray R.
        The contraceptive pill, side effects and personality: Report of a controlled double blind trial.
        Br J Psychiatry. 1970; 116: 169-172
        • Graham C.A.
        • Sherwin B.B.
        The relationship between mood and sexuality in women using an oral contraceptive as a treatment for premenstrual symptoms.
        Psychoneuroendocrinology. 1993; 18: 273-281
        • Graham C.A.
        • Ramos R.
        • Bancroft J.
        • Maglaya C.
        • Farley T.M.
        The effects of steroidal contraceptives on the well‐being and sexuality of women: A double‐blind, placebo‐controlled, two‐centre study of combined and progestogen‐only methods.
        Contraception. 1995; 52: 363-369
        • Sanders S.A.
        • Graham C.A.
        • Bass J.L.
        • Bancroft J.
        A prospective study of the effects of oral contraceptives on sexuality and well‐being and their relationship to discontinuation.
        Contraception. 2001; 64: 51-58
        • Davison S.L.
        • Bell R.J.
        • LaChina M.
        • Holden S.L.
        • Davis S.R.
        Sexual function in well women: Stratification by sexual satisfaction, hormone use, and menopause status.
        J Sex Med. 2008; 5: 1214-1222
        • Wallwiener C.W.
        • Wallwiener L.M.
        • Seeger H.
        • Mück A.O.
        • Bitzer J.
        • Wallwiener M.
        Prevalence of sexual dysfunction and impact of contraception in female German medical students.
        J Sex Med. 2010; 7: 2139-2148
        • Wallwiener M.
        • Wallwiener L.M.
        • Seeger H.
        • Mueck A.O.
        • Zipfel S.
        • Bitzer J.
        • Wallwiener C.W.
        Effects of sex hormones in oral contraceptives on the female sexual function score: A study in German female medical students.
        Contraception. 2009; 82: 155-159
        • Sherwin B.B.
        • Gelfand M.M.
        • Brender W.
        Androgen enhances sexual motivation in females: A prospective, crossover study of sex steroid administration in the surgical menopause.
        Psychosom Med. 1985; 47: 339-351
        • Shifren J.L.
        • Braunstein G.D.
        • Simon J.A.
        • Casson P.R.
        • Buster J.E.
        • Redmond G.P.
        • Burki R.E.
        • Ginsburg E.S.
        • Rosen R.C.
        • Leiblum S.R.
        • Caramelli K.E.
        • Mazer N.A.
        Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.
        N Engl J Med. 2000; 343: 682-688
        • Shifren J.L.
        • Davis S.R.
        • Moreau M.
        • Waldbaum A.
        • Bouchard C.
        • DeRogatis L.
        • Derzko C.
        • Bearnson P.
        • Kakos N.
        • O’Neill S.
        • Levine S.
        • Wekselman K.
        • Buch A.
        • Rodenberg C.
        • Kroll R.
        Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: Results from the INTIMATE NM1 Study.
        Menopause. 2006; 13: 770-779
        • Mohamed A.M.
        • El‐Sherbiny W.S.
        • Mostafa W.A.
        Combined contraceptive ring versus combined oral contraceptive (30‐mug ethinylestradiol and 3‐mg drospirenone).
        Int J Gynaecol Obstet. 2011; 114: 145-148
        • Gracia C.R.
        • Sammel M.D.
        • Charlesworth S.
        • Lin H.
        • Barnhart K.T.
        • Creinin M.D.
        Sexual function in first‐time contraceptive ring and contraceptive patch users.
        Fertil Steril. 2010; 93: 21-28
        • Guida M.
        • Di Spiezio Sardo A.
        • Bramante S.
        • Sparice S.
        • Acunzo G.
        • Tommaselli G.A.
        • Di Carlo C.
        • Pellicano M.
        • Greco E.
        • Nappi C.
        Effects of two types of hormonal contraception—Oral versus intravaginal—On the sexual life of women and their partners.
        Hum Reprod. 2005; 20: 1100-1106
        • Nelson A.L.
        Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception.
        J Reprod Med. 1996; 41: 391-400
        • Ott M.A.
        • Shew M.L.
        • Ofner S.
        • Tu W.
        • Fortenberry J.D.
        The influence of hormonal contraception on mood and sexual interest among adolescents.
        Arch Sex Behav. 2008; 37: 605-613
        • Schaffir J.A.
        • Isley M.M.
        • Woodward M.
        Oral contraceptives vs injectable progestin in their effect on sexual behavior.
        Am J Obstet Gynecol. 2010; 203: 545 e1-5
        • Gezginc K.
        • Balci O.
        • Karatayli R.
        • Colakoglu M.C.
        Contraceptive efficacy and side effects of Implanon.
        Eur J Contracept Reprod Health Care. 2007; 12: 362-365
        • Skrzypulec V.
        • Drosdzol A.
        Evaluation of quality of life and sexual functioning of women using levonorgestrel‐releasing intrauterine contraceptive system—Mirena.
        Coll Antropol. 2008; 32: 1059-1068
        • Grady W.R.
        • Billy J.O.
        • Klepinger D.H.
        Contraceptive method switching in the United States.
        Perspect Sex Reprod Health. 2002; 34: 135-145